About Alignment Healthcare, Inc. - Common Stock (ALHC)
Alignment Healthcare Inc is a leading healthcare company that focuses on providing innovative and personalized health care solutions, primarily for seniors. The company utilizes a technology-driven approach to deliver high-quality, value-based care, ensuring that patients receive tailored support and resources to manage their health effectively. By leveraging data analytics and a network of healthcare professionals, Alignment aims to improve health outcomes while enhancing patient experiences and reducing healthcare costs. The company emphasizes preventive care and proactive health management, positioning itself as a pivotal player in the evolving landscape of healthcare services for aging populations. Read More
In favor of a potential upward reversal we are technically very oversold right now, but we also have to acknowledge this is a rather crazy news-driven market prone to severe whipsaws.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Alignment Healthcare (NASDAQ:ALHC) and the rest of the health insurance providers stocks fared in Q4.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including CVS Health (NYSE:CVS) and its peers.
ALHC's fundamentals are robust, with a market cap of $3.33 billion, expected revenue growth of 38.69% this year, and earnings projected to increase 41.93%.
What a time it’s been for Alignment Healthcare. In the past six months alone, the company’s stock price has increased by a massive 64.1%, setting a new 52-week high of $18.13 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Cardinal Health (NYSE:CAH) and the best and worst performers in the healthcare providers & services industry.
Let’s dig into the relative performance of Clover Health (NASDAQ:CLOV) and its peers as we unravel the now-completed Q4 health insurance providers earnings season.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, including Molina Healthcare (NYSE:MOH) and its peers.
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the health insurance providers stocks, including Progyny (NASDAQ:PGNY) and its peers.
Shares of health insurance company Alignment Healthcare (NASDAQ:ALHC)
jumped 17.5% in the afternoon session after the company reported strong fourth-quarter 2024 results and provided optimistic full-year revenue and EBITDA guidance, exceeding analysts' expectations. Sales jumped 50.7% from last year, fueled by a 58.6% rise in health plan members, reaching 189,100 by year-end. Profitability improved as the company logged its first full year of positive adjusted EBITDA. Zooming out, this quarter underscored the company's ability to scale efficiently while positioning itself for sustained growth.
Health insurance company Alignment Healthcare (NASDAQ:ALHC) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 50.7% year on year to $701.2 million. On top of that, next quarter’s revenue guidance ($887.5 million at the midpoint) was surprisingly good and 4.1% above what analysts were expecting. Its GAAP loss of $0.16 per share was 11% above analysts’ consensus estimates.
ORANGE, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the following conferences:
ORANGE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its fourth quarter and full year ended Dec. 31, 2024.
Alignment Healthcare has been on fire lately. In the past six months alone, the company’s stock price has rocketed 60.1%, reaching $13.88 per share. This performance may have investors wondering how to approach the situation.
ORANGE, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its fourth quarter and full-year 2024 financial results on Thursday, Feb. 27, 2025, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EST.
